← FDA Drug Approvals (Drugs@FDA)

SYMPROIC

NDA · New Drug Application · Sponsor: BDSI · Approved 2017-03-23

Drug application

FDA Application #

NDA208854

Application type

New Drug Application

Brand name

SYMPROIC

Generic name

NALDEMEDINE

Active ingredients

NALDEMEDINE TOSYLATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

BDSI

Manufacturer

BioDelivery Sciences International Inc

First approval

2017-03-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown